Iminodiacetic acid,disodium salt hydrate

Modify Date: 2025-08-26 17:52:11

Iminodiacetic acid,disodium salt hydrate Structure
Iminodiacetic acid,disodium salt hydrate structure
Common Name Iminodiacetic acid,disodium salt hydrate
CAS Number 17593-73-6 Molecular Weight 195.08200
Density 1.436g/cm3 Boiling Point 370.6ºC at 760mmHg
Molecular Formula C4H7NNa2O5 Melting Point 180 °C
MSDS Chinese USA Flash Point 177.9ºC
Symbol GHS07
GHS07
Signal Word Warning

 Names

Name iminodiacetic acid disodium salt hydrate
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.436g/cm3
Boiling Point 370.6ºC at 760mmHg
Melting Point 180 °C
Molecular Formula C4H7NNa2O5
Molecular Weight 195.08200
Flash Point 177.9ºC
Exact Mass 195.01200
PSA 101.52000
InChIKey NRNKQUKJDKJJEX-UHFFFAOYSA-L
SMILES O.O=C([O-])CNCC(=O)O.O=C([O-])CNCC(=O)O.[Na+].[Na+]

 MSDS

Name: Iminodiacetic Acid Disodium Salt Monohydrate 97% Material Safety Data Sheet
Synonym: Disodium Iminodiacetate Monohydrat
CAS: 17593-73-6
Section 1 - Chemical Product MSDS Name:Iminodiacetic Acid Disodium Salt Monohydrate 97% Material Safety Data Sheet
Synonym:Disodium Iminodiacetate Monohydrat

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
17593-73-6 Iminodiacetic Acid, Disodium Salt Mono 97 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid if irritation or symptoms occur.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 17593-73-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 180 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: moderately soluble
Specific Gravity/Density:
Molecular Formula: C4H5NO4Na2.H2O
Molecular Weight: 195.08

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 17593-73-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Iminodiacetic Acid, Disodium Salt Monohydrate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 17593-73-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 17593-73-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 17593-73-6 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi: Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S36-S24/25-S23
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2922499990

 Customs

HS Code 2922499990
Summary HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

 Synonyms

EINECS 213-181-8
MFCD00150689
DISODIUM IMINODIACETATE HYDRATE
IMINODIACETIC ACID D
SodiuM iMinodiacetate Monohydrate
IMINODIACETIC ACID DISODIUM
iminodi-acetic acid,disodium salt
Iminodi-essigsaeure,Dinatriumsalz
Iminodiacetic acid disodium salt hydrate
sodiumiminodiacetate
Iminodiacetic acid sodium salt
DISODIUM IMINODIACETATE MONOHYDRATE
DIGLYCINE DISODIUM SALT
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Iminodiacetic acid,disodium salt hydrate suppliers

Iminodiacetic acid,disodium salt hydrate price

Related Compounds: More...
Iminodiacetic acid disodium salt hydrate
77752-63-7
IMINODIACETIC ACID, DISODIUM SALT HYDRAT
207398-95-6
Phosphoric acid, disodium salt, hydrate
10140-65-5
Argininosuccinic acid disodium
918149-29-8
Disodium iminodiacetate
928-72-3
N-(p-Vinylbenzyl)iminodiacetic acid, disodium salt, p-divinylbenzene polymer
70660-50-3
1,5-naphthalenedisulfonic acid, disodium salt hydrate
207569-02-6
N-(2-Acetamido)iminodiacetic acid disodium salt
41689-31-0
DNP-L-cysteic acid disodium salt hydrate
16068-14-7
5-((2-Fluorophenyl)(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)methyl)-2-(furan-2-yl)thiazolo[3,2-b][1,2,4]triazol-6-ol
887221-62-7
5-[(2-Fluorophenyl)(morpholin-4-yl)methyl]-2-(furan-2-yl)-[1,2,4]triazolo[3,2-b][1,3]thiazol-6-ol
887221-65-0
8-(sec-butyl)-3-butyl-1,7-dimethyl-1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione
941951-01-5
N-(4-chlorobenzyl)-2-((1-(furan-2-ylmethyl)-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl)thio)acetamide
946219-41-6
5-((4-Benzylpiperazin-1-yl)(2-fluorophenyl)methyl)-2-(furan-2-yl)thiazolo[3,2-b][1,2,4]triazol-6-ol
887221-77-4
2-((2-oxo-1-(pyridin-3-ylmethyl)-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl)thio)-N-(m-tolyl)acetamide
946325-98-0
5-((2-Fluorophenyl)(4-(2-fluorophenyl)piperazin-1-yl)methyl)-2-(furan-2-yl)thiazolo[3,2-b][1,2,4]triazol-6-ol
887221-81-0
N-(2,3-dimethylphenyl)-2-((2-oxo-1-(pyridin-2-ylmethyl)-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl)thio)acetamide
946219-53-0
5-((2-Fluorophenyl)(4-(4-methoxyphenyl)piperazin-1-yl)methyl)-2-(furan-2-yl)thiazolo[3,2-b][1,2,4]triazol-6-ol
887221-85-4
5-((4-Fluorophenyl)(pyrrolidin-1-yl)methyl)-2-(furan-2-yl)thiazolo[3,2-b][1,2,4]triazol-6-ol
887221-95-6